Understanding FcRn Inhibition and Pathogenic IgG Reduction in MG

21 Oct 2026 0 comments

FcRn inhibition targets the persistence of pathogenic IgG rather than its production. The panel explains why this downstream mechanism can provide relatively rapid control in MG.

Source: NeurologyLive Published 21 Oct 2026 Imported 21 Oct 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment